+27.0%
MRNA vs FBTC
+62.0%
-35.1%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | FBTC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.3% | -3.1% | -3.3% |
| 7D | -10.1% | +1.1% | -11.2% | -10.5% |
| 30D | +126.7% | +22.3% | +104.5% | +110.6% |
| 3M | +184.1% | +26.0% | +158.1% | +161.8% |
| 6M | +143.3% | +13.2% | +130.1% | +129.8% |
| YTD | +359.9% | -10.7% | +370.6% | +354.9% |
| 1Y | +454.2% | -30.0% | +484.1% | +473.7% |
| All | +27.0% | +62.0% | -35.1% | +12.8% |
Cumulative growth
Daily Returns
Daily percentage return beside FBTC.
Daily Out/Under-Performance
Portfolio return minus FBTC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FBTC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded FBTC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling